Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

This interview discusses how BCMA-directed CAR T-cell therapy in multiple myeloma may be more effective when administered ...

ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...

Wang also acknowledges emerging platforms such as CAR NK cells and in vivo CAR T technologies but notes these remain ...

A Las Vegas hospital has achieved a major milestone as staff celebrates the completion of its 100th stem cell transplant.

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...

Orca Bio has disclosed $250 million in funding, flooding its balance sheet with cash to buoy preparations for the ...

Highlights from JPMorgan's 2026 healthcare conference cover patient cash payments for obesity drugs, renewed biotech IPO ...

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...